Search results for CRKL

Anti-CrkL (phospho Y207) antibody [EP270Y], Abcam, AB52908

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Species reactivity Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.

Phospho-CRKL-Y207 Rabbit pAb- ABclonal, ABclonal, AP0824

Phospho-CRKL-Y207 Rabbit pAb- ABclonal, ABclonal, AP1452

Rat Crk-Like Protein (CRKL) ELISA Kit, Abbexa, abx392108

Rat Crk-Like Protein (CRKL) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat CRKL concentrations in serum, plasma and other biological fluids.

Mouse Crk Like Protein (CRKL) ELISA Kit, Abbexa, abx153873

Mouse Crk Like Protein (CRKL) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Mouse Crk Like Protein (CRKL) concentrations in tissue homogenates, cell lysates and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Crk Like Protein (CRKL)No significant cross-reactivity or interference between Crk Like Protein (CRKL) and analogues was observed.

Anti-CrkL antibody [Y243] - BSA and Azide free, Abcam, AB247234

ab247234 is the carrier-free version of ab32126 . Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

Anti-CrkL antibody [Y244] - BSA and Azide free, Abcam, AB247210

ab247210 is the carrier-free version of ab32018 . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.

Anti-CrkL (phospho Y207) antibody [CrkLY207-G4], Abcam, AB278698

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Human Crk Like Protein (CRKL) ELISA Kit, Abbexa, abx151185

Human Crk Like Protein (CRKL) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Crk Like Protein (CRKL) concentrations in tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Crk Like Protein (CRKL)No significant cross-reactivity or interference between Crk Like Protein (CRKL) and analogues was observed.

PE Anti-CrkL (phospho Y207) antibody [CrkLY207-G4], Abcam, AB278546

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .